Larvol Delta - Evommune-Initiates-Phase-2-Trial-of-IL18-Targeted-Fusion-Protein-EVO301-in-Adult-Patients-with-Atopic-Dermatitis

EVO301 - Evommune

https://www.prnewswire.com/news-releases/evommune-initiates-phase-2-trial-of-il-18-targeted-fusion-protein-evo301-in-adult-patients-with-atopic-dermatitis-302402614.html

Mar 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next